BusinessAxim Biotechnologies Reports Third Quarter 2017 ResultsBy Nasdaq OMXNov 22, 2017, 3:00 PM UTC
BusinessAxim Biotechnologies Announces Phase IIa Trial Results Validating its Proprietary Cannabinoid Delivery Method for Treatment of Irritable Bowel Syndrome (IBS)By Nasdaq OMXNov 21, 2017, 2:00 PM UTC
BusinessEarth Science Tech Inc. Announces New Corporate Facility & participates in its First Trade Expo in DecemberBy Nasdaq OMXNov 16, 2017, 1:00 PM UTC
BusinessMadrigal Pharmaceuticals Reports 2017 Third Quarter Financial ResultsBy Nasdaq OMXNov 9, 2017, 12:50 PM UTC
BusinessNew Digital Therapeutics Are the Best Hope to Address DementiaBy Nasdaq OMXNov 9, 2017, 9:00 AM UTC
BusinessCure Pharmaceutical Enters Into Product Development Agreement with Therapix Biosciences To Develop Cannabinoid-Based Product For Sleep DisordersBy Nasdaq OMXNov 7, 2017, 2:00 PM UTC
BusinessAclara Research Continues to Lead the Cannabis Industry with Release of Latest StudyBy Nasdaq OMXNov 1, 2017, 1:03 PM UTC
BusinessMadrigal Pharmaceuticals Presents Preclinical Results Supporting the Therapeutic Potential of its Lead β-Selective Thyroid Hormone Receptor Agonist, MGL-3196, at AASLD Liver MeetingBy Nasdaq OMXOct 23, 2017, 11:00 AM UTC
